Modulation of c-Myb-induced transcription activation by a phosphorylation site near the negative regulatory domain.

AUTOR(ES)

Aziz, N

RESUMO

The c-myb protooncogene encodes a highly conserved transcription factor that functions as both an activator and a repressor of transcription. The v-myb oncogenes of E26 leukemia virus and avian myeloblastosis virus encode proteins that are truncated at both the amino and the carboxyl terminus, deleting portions of the c-Myb DNA-binding and negative regulatory domains. This has led to speculation that the deleted regions contain important regulatory sequences. We previously reported that the 42-kDa mitogen-activated protein kinase (p42mapk) phosphorylates chicken and murine c-Myb at multiple sites in the negative regulatory domain in vitro, suggesting that phosphorylation might provide a mechanism to regulate c-Myb function. We now report that three tryptic phosphopeptides derived from in vitro phosphorylated c-Myb comigrate with three tryptic phosphopeptides derived from metabolically labeled c-Myb immunoprecipitated from murine erythroleukemia cells. At least two of these peptides are phosphorylated on serine-528. Replacement of serine-528 with alanine results in a 2- to 7-fold increase in the ability of c-Myb to transactivate a Myb-responsive promoter/reporter gene construct. These findings suggest that phosphorylation serves to regulate c-Myb activity and that loss of this phosphorylation site from the v-Myb proteins may contribute to their transforming potential.

Documentos Relacionados

• Ca2+- and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain.
• Activation of mammalian DNA methyltransferase by cleavage of a Zn binding regulatory domain.
• Activation of c-Jun transcription factor by substitution of a charged residue in its N-terminal domain.
• ATF-2 contains a phosphorylation-dependent transcriptional activation domain.
• Transcriptional activation and transformation by FosB protein require phosphorylation of the carboxyl-terminal activation domain.